A study of sodium deficiency in cirrhosis of liver patients
Not Applicable
- Conditions
- Health Condition 1: K746- Other and unspecified cirrhosis ofliver
- Registration Number
- CTRI/2019/10/021544
- Lead Sponsor
- Department of General Meidicne
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.All the indoor patients presenting with hyponatremia <135meq/l in liver cirrhosis.
2.Diagnosis of having liver cirrhosis by clinically and ultrasonographical findings.
Exclusion Criteria
1.Patientâ??s age <12years.
2.Patient having hyponatremia without liver cirrhosis.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To study the clinical presentation of patients with hyponatremia in cirrhosis of liver. <br/ ><br>2.To study the severity of hyponatremia and complications of cirrhosis of liver. <br/ ><br>Timepoint: 2 years <br/ ><br>
- Secondary Outcome Measures
Name Time Method To study the prevalence of hyponatremia in patients with cirrhosis of liver. <br/ ><br>Timepoint: 2 years
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie hyponatremia in cirrhosis patients studied in CTRI/2019/10/021544?
How does hyponatremia in cirrhosis impact patient outcomes compared to standard-of-care management?
Are there specific biomarkers that correlate with hyponatremia severity in liver cirrhosis patients?
What are the potential adverse events associated with sodium imbalance in cirrhosis patients and their management?
What recent advancements in sodium regulation therapies for cirrhosis patients have emerged alongside observational studies like CTRI/2019/10/021544?